Cart
sales@molnova.com
Home - Products - Angiogenesis - VEGFR - UNC0064-12 hydrochloride (1430089-64-7(free base))

UNC0064-12 hydrochloride (1430089-64-7(free base))

CAS No. ——

UNC0064-12 hydrochloride (1430089-64-7(free base))( —— )

Catalog No. M22768 CAS No. ——

UNC0064-12 hydrochloride is an inhibitor of VEGFR2 extracted from patent WO2013055780A1.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 357 In Stock
10MG 597 In Stock
25MG 882 In Stock
50MG 1350 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    UNC0064-12 hydrochloride (1430089-64-7(free base))
  • Note
    Research use only, not for human use.
  • Brief Description
    UNC0064-12 hydrochloride is an inhibitor of VEGFR2 extracted from patent WO2013055780A1.
  • Description
    UNC0064-12 hydrochloride is an inhibitor of VEGFR2 extracted from patent WO2013055780A1.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    VEGFR
  • Recptor
    VEGFR2
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    ——
  • Formula Weight
    400.91
  • Molecular Formula
    C19H25ClN8
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Cl.NCCCNc1ccc(Nc2nccc(Nc3cc([nH]n3)C3CC3)n2)cc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. MULTIPLEXED KINASE INHIBITOR BEADS AND USES THEREOF. Patent Application WO/2013/055780 Kind Code: A1
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • Lariciresinol

    Lariciresinol is an enterolignan precursor, it possesses fungicidal activities by disrupting the fungal plasma membrane and therapeutic potential as a novel antifungal agent for the treatment of fungal infectious diseases in humans. Dietary lariciresinol can attenuate mammary tumor growth and reduce blood vessel density in human MCF-7 breast cancer xenografts and carcinogen-induced mammary tumors in rats.

  • Parsatuzumab

    Parsatuzumab (RG 7414) is a humanized monoclonal antibody targeting EGFL7, which is also used as an immunomodulator.

  • SU5208

    SU5208 is a compound with bioactivity.SU5208 inhibits vascular endothelial growth factor receptor-2 (VEGFR2).

Sign In Join Free